{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T03:41:54Z","timestamp":1780371714706,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004740","name":"Fondazione del Monte di Bologna e Ravenna","doi-asserted-by":"publisher","award":["451bis\/2015"],"award-info":[{"award-number":["451bis\/2015"]}],"id":[{"id":"10.13039\/501100004740","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004740","name":"Fondazione del Monte di Bologna e Ravenna","doi-asserted-by":"publisher","award":["451bis\/2015"],"award-info":[{"award-number":["451bis\/2015"]}],"id":[{"id":"10.13039\/501100004740","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00415-018-8848-1","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T23:42:27Z","timestamp":1522798947000},"page":"1343-1352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Supervised versus unsupervised technology-based levodopa monitoring in Parkinson\u2019s disease: an intrasubject comparison"],"prefix":"10.1007","volume":"265","author":[{"given":"Giovanna","family":"Lopane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabato","family":"Mellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Corzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Chiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Cortelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Calandra-Buonaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6399-9999","authenticated-orcid":false,"given":"Manuela","family":"Contin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"key":"8848_CR1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mds.26642","volume":"31","author":"AJ Espay","year":"2016","unstructured":"Espay AJ, Bonato P, Nahab FB, Maetzler W, Dean JM, Klucken J et al (2016) Movement disorders society task force on technology technology in Parkinson\u2019s disease: challenges and opportunities. Mov Disord 31:1272\u20131282","journal-title":"Mov Disord"},{"key":"8848_CR2","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1002\/mds.26673","volume":"31","author":"W Maetzler","year":"2016","unstructured":"Maetzler W, Klucken J, Horne M (2016) A clinical view on the development of technology-based tools in managing Parkinson\u2019s disease. Mov Disord 31:1263\u20131271","journal-title":"Mov Disord"},{"key":"8848_CR3","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/mds.26744","volume":"31","author":"ER Dorsey","year":"2016","unstructured":"Dorsey ER, Vlaanderen FP, Engelen LJ, Kieburtz K, Zhu W, Biglan KM, Faber MJ, Bloem BR (2016) Moving Parkinson care to the home. Mov Disord 31:1258\u20131262","journal-title":"Mov Disord"},{"key":"8848_CR4","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/1531-8257(200007)15:4<641::AID-MDS1007>3.0.CO;2-2","volume":"15","author":"CN Homann","year":"2000","unstructured":"Homann CN, Suppan K, Wenzel K, Giovannoni G, Ivanic G, Horner S, Ott E, Hartung HP (2000) The bradykinesia akinesia incoordination test (BRAIN TEST), an objective and user-friendly means to evaluate patients with parkinsonism. Mov Disord 15:641\u2013647","journal-title":"Mov Disord"},{"key":"8848_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1353-8020(00)00048-1","volume":"7","author":"PK Pal","year":"2001","unstructured":"Pal PK, Lee CS, Samii A, Schulzer M, Stoessl AJ, Mak EK, Wudel J, Dobko T, Tsui JK (2001) Alternating two finger tapping with contralateral activation is an objective measure of clinical severity in Parkinson\u2019s disease and correlates with PET. Parkinsonism Relat Disord 7:305\u2013309","journal-title":"Parkinsonism Relat Disord"},{"key":"8848_CR6","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/mds.20556","volume":"20","author":"AL Taylor Tavares","year":"2005","unstructured":"Taylor Tavares AL, Jefferis GS, Koop M, Hill BC, Hastie T, Heit G, Bronte-Stewart HM (2005) Quantitative measurements of alternate finger tapping in Parkinson\u2019s disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation. Mov Disord 20:1286\u20131298","journal-title":"Mov Disord"},{"key":"8848_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1532-5415.1991.tb01616.x","volume":"39","author":"D Podsiadlo","year":"1991","unstructured":"Podsiadlo D, Richardson S (1991) The timed \u201cUp & Go\u201d: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142\u2013148","journal-title":"J Am Geriatr Soc"},{"key":"8848_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00002826-199002000-00002","volume":"13","author":"M Contin","year":"1990","unstructured":"Contin M, Riva R, Martinelli P, Procaccianti G, Cortelli P, Avoni P, Baruzzi A (1990) Response to a standard oral levodopa test in parkinsonian patients with and without motor fluctuations. Clin Neuropharmacol 13:19\u201328","journal-title":"Clin Neuropharmacol"},{"key":"8848_CR9","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00007691-200112000-00005","volume":"23","author":"M Contin","year":"2001","unstructured":"Contin M, Riva R, Martinelli P, Albani F, Avoni P, Baruzzi A (2001) Levodopa therapy monitoring in patients with Parkinson\u2019s disease: a kinetic\u2013dynamic approach. Ther Drug Monit 23:621\u2013629","journal-title":"Ther Drug Monit"},{"key":"8848_CR10","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/s00415-015-7961-7","volume":"263","author":"G Calandra-Buonaura","year":"2016","unstructured":"Calandra-Buonaura G, Doria A, Lopane G, Guaraldi P, Capellari S, Martinelli P, Cortelli P, Contin M (2016) Pharmacodynamics of a low subacute levodopa dose helps distinguish between multiple system atrophy with predominant Parkinsonism and Parkinson\u2019s disease. J Neurol 263:250\u2013256","journal-title":"J Neurol"},{"key":"8848_CR11","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(14)60962-4","volume":"384","author":"AE Lang","year":"2014","unstructured":"Lang AE, Marras C (2014) Initiating dopaminergic treatment in Parkinson\u2019s disease. Lancet 384:1164\u20131166","journal-title":"Lancet"},{"key":"8848_CR12","unstructured":"European innovation partnership on active and healthy ageing. Action group A1 (2013) A compilation of good practices. Prescription and adherence to medical plans. \n                    https:\/\/ec.europa.eu\/research\/innovation-union\/pdf\/active-healthy-ageing\/gp_a1.pdf\n                    \n                  . Accessed 29 Nov 2017"},{"key":"8848_CR13","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/mds.26313","volume":"30","author":"G Lopane","year":"2015","unstructured":"Lopane G, Mellone S, Chiari L, Cortelli P, Calandra-Buonaura G, Contin M (2015) Dyskinesia detection and monitoring by a single sensor in patients with Parkinson\u2019s Disease. Mov Disord 30:1267\u20131271","journal-title":"Mov Disord"},{"key":"8848_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archneur.56.1.33","volume":"56","author":"DJ Gelb","year":"1999","unstructured":"Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson\u2019s disease. Arch Neurol 56:33\u201339","journal-title":"Arch Neurol"},{"key":"8848_CR15","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1002\/mds.10473","volume":"18","author":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease","year":"2003","unstructured":"Movement Disorder Society Task Force on Rating Scales for Parkinson\u2019s Disease (2003) The Unified Parkinson\u2019s Disease Rating Scale (UPDRS): status and recommendations. Mov Disord 18:738\u2013750","journal-title":"Mov Disord"},{"key":"8848_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 12:189\u2013198","journal-title":"J Psychiatry Res"},{"key":"8848_CR17","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1136\/jnnp.2008.147629","volume":"79","author":"JP Taylor","year":"2008","unstructured":"Taylor JP, Rowan EN, Lett D, O\u2019Brien JT, McKeith IG, Burn DJ (2008) Poor attentional function predicts cognitive decline in patients with non-demented Parkinson\u2019s disease independent of motor phenotype. J Neurol Neurosurg Psychiatry 79:1318\u20131323","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8848_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/00002826-199210000-00003","volume":"15","author":"RP Irwin","year":"1992","unstructured":"Irwin RP, Nutt JG, Woodward WR, Gancher ST (1992) Pharmacodynamics of the hypotensive effect of levodopa in parkinsonian patients. Clin Neuropharmacol 15:365\u2013374","journal-title":"Clin Neuropharmacol"},{"key":"8848_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/1531-8257(199905)14:3<448::AID-MDS1010>3.0.CO;2-0","volume":"14","author":"P Hagell","year":"1999","unstructured":"Hagell P, Widner H (1999) Clinical rating of dyskinesias in Parkinson\u2019s disease: use and reliability of a new rating scale. Mov Disord 14:448\u2013455","journal-title":"Mov Disord"},{"key":"8848_CR20","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"15","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clark CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov Disord 15:2649\u20132653","journal-title":"Mov Disord"},{"key":"8848_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000300647","volume":"63","author":"F Stocchi","year":"2010","unstructured":"Stocchi F, Jenner P, Obeso JA (2010) When do levodopa motor fluctuations first appear in Parkinson\u2019s disease? Eur Neurol 63:257\u2013266","journal-title":"Eur Neurol"},{"key":"8848_CR22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1001\/archneurol.2009.295","volume":"67","author":"LM Shulman","year":"2010","unstructured":"Shulman LM, Gruber-Baldini AL, Anderson KE, Fishman PS, Reich SG, Weiner WJ (2010) The clinically important difference on the Unified Parkinson\u2019s disease Rating Scale. Arch Neurol 67:64\u201370","journal-title":"Arch Neurol"},{"key":"8848_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.parkreldis.2015.02.026","volume":"21","author":"S Arora","year":"2015","unstructured":"Arora S, Venkataraman V, Zhan A, Donohue S, Biglan KM, Dorsey ER, Little MA (2015) Detecting and monitoring the symptoms of Parkinson\u2019s disease using smartphones: a pilot study. Parkinsonism Relat Disord 21:650\u2013653","journal-title":"Parkinsonism Relat Disord"},{"key":"8848_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00273","author":"G Mitsi","year":"2017","unstructured":"Mitsi G, Mendoza EU, Wissel BD, Barbopoulou E, Dwivedi AK, Tsoulos I, Stavrakoudis A, Espay AJ, Papapetropoulos S (2017) Biometric digital health technology for measuring motor function in Parkinson\u2019s disease: results from a feasibility and patient satisfaction study. Front Neurol. \n                    https:\/\/doi.org\/10.3389\/fneur.2017.00273","journal-title":"Front Neurol"},{"key":"8848_CR25","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/mds.26317","volume":"30","author":"W Maetzler","year":"2015","unstructured":"Maetzler W, Rochester L (2015) Body-worn sensors\u2014the brave new world of clinical measurement? Mov Disord 30:1203\u20131205","journal-title":"Mov Disord"},{"key":"8848_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0124763","author":"N Toosizadeh","year":"2015","unstructured":"Toosizadeh N, Mohler J, Lei H, Parvaneh S, Sherman S, Najafi B (2015) Motor performance assessment in Parkinson\u2019s disease: association between objective in-clinic, objective in-home, and subjective\/semi-objective measures. PLoS One. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0124763","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"8848_CR27","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1016\/j.parkreldis.2017.07.022","volume":"46","author":"CA Artusi","year":"2018","unstructured":"Artusi CA, Mishra M, Latimer P, Vizcarra JA, Lopiano L, Maetzler W, Merola A, Espay AJ (2018) Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases. Parkinsonism Relat Disord 46(Suppl 1):S53\u2013S56","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-018-8848-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-018-8848-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T20:54:04Z","timestamp":1553806444000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-018-8848-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8848"],"URL":"https:\/\/doi.org\/10.1007\/s00415-018-8848-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]},"assertion":[{"value":"12 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"G. Lopane and M. Corzani received a Grant from \u201cFondazione del Monte di Bologna e Ravenna\u201d (Grant no. 451bis\/2015). The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Ethics Committee of the Bologna-Imola Local Health Trust (Protocol number 15111) and was performed in accordance with the ethical standards of the Declaration of Helsinki and its later amendments. Patients gave their written informed consent to study participation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}